About Mesothelioma |
Types of Mesothelioma |
Traditional Treatment |
Experimental Treatment |
Treatment by Stage
Palliative Care | Clinical Trials | Help&Support | Hospitals By State | Legal Advice | Asbestos-Related Diseases
Side Effects of Mesothelioma treatment
Almost everyone who receives cancer treatment experiences side effects. Relieving side effects is an important part of treatment.
They appear especially by using chemotherapy and radiation therapy. Side effects are the following:
Practically every person, who received cancer therapy, suffers from side effects. An alleviation side effect is a very important part of therapy.
Cancer and cancer therapy cause different side effects; some of them can easily managed and others demand particularized care. There you can see some side effects that are more usual to mesothelioma therapy:
Alvine flux is loose, abundant or watery bowel movements. It is an ordinary side effect of certain chemotherapeutical medicines or of radiation therapy to the calyx, such as in women with fallopian, ovarian or jugular cancers. It can also produced by specific tumors, kind of pancreatic cancer.
Tiredness is the ultimate defatigation or fatigue, and is the most ordinary complication that people with cancer suffer. More than half of patients suffer from tiredness during radiotherapeutics or chemotherapeutics, and more than 70% of patients with advanced cancer suffer from tiredness.
Fluid in the peritoneal cavity (hydroperitonium)
Hydroperitoncum is the uptake of fluid in the peritoneal cavity, in the region around the organs, called abdomen. 10% of all hydroperitoncums is caused by cancer and is called cancerous hydroperitoncums. Most cancer-related hydroperitoncums have patients with cancers of the ootheca, mammary gland, endometrium (lining of the uterus), large bowel, pancreas or gastrointestinal (GI) system. Some people with hydroperitoncums may suffer from the weight increment, transabdominal swelling, a sense of bulging plentitude or bulging, a sense of severity, stomach upset, qualm and/or emesis, mariscas (a circumstance when a person feels sickly around the anus), ankle intumescing or changes to the umbilicus.
Cancerous pleural ejecta (Fluid around the lungs)
Pleural ejecta is a circumstance distinguished by excessive fluid building up in the pleural cavity, the area between the border of the lungs and the thoracic wall. Nearly 50% of patients with cancer have pleural ejecta. More than 75% of patients with cancerous pleural ejecta have cancers of the mammary gland, lung, ootheca or have lymphoma. The features of a pleural ejecta are shortness of breath, short cough, hurt, feeling of chest severity, disability to drill, and discomfort (feeling sick).
Baldness (hair loss)
An eventual side effect of chemotherapeutics and radiotherapeutics is baldness. Chemotherapeutics and radiotherapeutics cause baldness by impairing the hair follicles respondent for hair growth. Baldness may be evident throughout the body: face, head, arms, underarms, legs and pubic zone. The hair may fall out fully, little by little, or in sections. Sometimes, the hair will simply thin‚sometimes unnoticeably‚ hand may become dryer and duller. Losing one's hair leads to an emotionally and psychologically challenging feeling and can act a patient's life quality and self-concept. Nevertheless, the baldness is generally provisional, and the hair then grows back. But not in every case the patient will have baldness during chemotherapeutics. The process of loosing hair usually begins within two weeks of starting chemotherapeutics and proceeding until 1-2 months later (Hair Loss, American Cancer Society). This can be quite discomfortable, but you should understand, that your hair will grow back after chemotherapeutics ends. You may consider wearing a mucket, cravat or turban in the interim.
A contagion is evident when injurious viruses, germ or fungi (for example, yeast) intrude the body and the immune system can not wreck them fast. Patients, who have cancer, are more likely to expand contagions because cancer and cancer therapy (specifically radiotherapeutics and chemotherapeutics to the bones or extended zones of the body) can slacken the immune system. Features of contagion include fever heat (temperature of 100.5?‚?°F or higher); rigor or perspiration; injury throat or abscess in the mouth; abdominal migraine; burning when urinating or repetitive urination; alvine flux or abscess around the anus; tussis or labored breathing; rubeosis, inflation, or pain around a cut or injury; and strange vaginal discharges.
Cytopenia is a shortage of blood cells. It can expand during cancer therapy because of the poison action of medicine on bone marrow. Then a person may expand abnormally low number of cells, so the patient can get an anemia (low number of red blood cells), leukopenia or neutropenia (low number of white blood cells), thrombocytopenia (platelets). If anemia is severe, then the person should take darbepoietin or erythropoietin for increasing the number of red blood cells or sometimes the doctor can transfuse packed red blood cells. Likewise, when thrombocytopenia is severe, the doctor may transfuse platelets to lower the risk of bleeding.
A patient, who has neutropenia is at higher risk of extension an contagion. A fever heat more than 100.4?‚?° F in a person with neutropenia is treated as an exceeding. Such a patient must be estimated for contagion and may demand hospitalization or antibiotics. White blood cells are hardly ever transfused, because they survive a shot period of time and can produce various side effects. Instead of it, certain materials (such as granulocyte-colony stimulant factor) help to actuate the production of white blood cells.
|Your Ads Here|
|Site map | Contact us
© 2006—2018 Mesothelioma Control